JMOM:NYE-JPMorgan U.S. Momentum Factor ETF (USD)

ETF | Others |

Last Closing

USD 31.2

Change

-0.40 (-1.27)%

Market Cap

USD 0.06B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-01-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.04 (+0.21%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.11 (-0.20%)

USD 32.78B
LCR Leuthold Core ETF

-0.09 (-0.27%)

USD 32.52B
DTB DTB

-0.12 (-0.63%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

-0.03 (-0.10%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 22.47B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear..

-0.07 (-0.22%)

USD 16.23B
DFUV Dimensional US Marketwide Valu..

+0.04 (+0.10%)

USD 10.15B
AVUV Avantis® U.S. Small Cap Value..

+0.02 (+0.02%)

USD 10.05B

ETFs Containing JMOM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.60% 84% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.60% 84% B 79% B-
Trailing 12 Months  
Capital Gain 21.52% 80% B- 78% C+
Dividend Return 0.65% 15% F 7% C-
Total Return 22.18% 80% B- 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.45% 75% C 55% F
Dividend Return 3.93% 72% C 40% F
Total Return 0.48% 35% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 7.38% 57% F 86% B+
Risk Adjusted Return 53.27% 73% C 58% F
Market Capitalization 0.06B 58% F 17% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.